Sponsor or institution
Clinical trials and research at Max Biopharma, INC.
As of November 12, 2026, Find a Trial lists 2 NIH-funded research projects at this institution, with $1.3 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2NIH research projects
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Oxy210 as an anti-fibrotic and immune-modulating approach for cystic fibrosis
A small-fund, early-phase program tests whether Oxy210 can reduce lung scarring and abnormal immune responses in people with cystic fibrosis.
-
Investigating a new drug to treat liver fibrosis caused by non-alcoholic steatohepatitis
This study is looking at a new treatment called Oxy210 that might help people with non-alcoholic steatohepatitis (NASH) by reducing liver scarring and inflammation, and it’s designed to be taken easily by mouth.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.